Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SWEDISH ORPHAN BIOVITRUM A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   1.4% 1.5% 1.7% 1.6% 1.9% 1.9% 7.5% 7.4%   Credit score (0-100)   79 78 73 73 69 68 32 33   Credit rating   A A A A A A BB BBB   Credit limit (kDKK)   119.9 103.2 28.5 50.8 6.5 8.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   35,274 31,624 39,028 32,623 23,486 22,183 0.0 0.0   EBITDA   4,439 4,283 5,112 3,912 3,653 4,242 0.0 0.0   EBIT   4,403 4,256 5,103 3,896 3,644 4,234 0.0 0.0   Pre-tax profit (PTP)   4,760.7 4,697.9 5,533.5 4,318.3 4,231.3 5,510.3 0.0 0.0   Net earnings   3,602.4 3,491.9 4,278.4 3,349.7 3,173.3 4,187.7 0.0 0.0   Pre-tax profit without non-rec. items   4,761 4,698 5,533 4,318 4,231 5,510 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   44.7 17.6 49.5 33.5 24.1 16.1 0.0 0.0   Shareholders equity total   13,175 16,667 20,946 24,295 27,469 31,656 31,156 31,156   Interest-bearing liabilities   888 1,291 0.0 735 0.0 315 0.0 0.0   Balance sheet total (assets)   28,466 30,767 36,717 33,718 32,145 36,485 31,156 31,156   Net Debt   884 1,290 -1.0 735 -2,450 -3,089 -31,156 -31,156     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   35,274 31,624 39,028 32,623 23,486 22,183 0.0 0.0   Gross profit growth   -12.7% -10.3% 23.4% -16.4% -28.0% -5.5% -100.0% 0.0%   Employees   0 0 0 0 0 10 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   28,466 30,767 36,717 33,718 32,145 36,485 31,156 31,156   Balance sheet change%   20.7% 8.1% 19.3% -8.2% -4.7% 13.5% -14.6% 0.0%   Added value   4,438.8 4,282.9 5,111.8 3,912.3 3,659.7 4,242.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -71 -54 24 -32 -19 -16 -16 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.5% 13.5% 13.1% 11.9% 15.5% 19.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.4% 16.0% 16.5% 12.4% 13.0% 16.1% 0.0% 0.0%   ROI %   38.8% 29.5% 28.6% 19.0% 16.3% 18.6% 0.0% 0.0%   ROE %   31.7% 23.4% 22.7% 14.8% 12.3% 14.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   46.3% 54.2% 57.0% 72.1% 85.5% 86.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   19.9% 30.1% -0.0% 18.8% -67.1% -72.8% 0.0% 0.0%   Gearing %   6.7% 7.7% 0.0% 3.0% 0.0% 1.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.9% 2.9% 3.9% 12.0% 11.7% 17.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.8 2.3 2.8 3.6 6.8 7.5 0.0 0.0   Current Ratio   1.8 2.3 2.8 3.6 6.8 7.5 0.0 0.0   Cash and cash equivalent   4.6 1.0 1.0 0.0 2,450.1 3,404.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   12,974.3 17,207.2 23,410.4 24,096.2 27,274.6 31,461.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 424 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 424 0 0   EBIT / employee   0 0 0 0 0 423 0 0   Net earnings / employee   0 0 0 0 0 419 0 0